Market Overview:
The global long-term asthma drugs market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of asthma, rising awareness about long-term asthma drugs, and technological advancements in the field of drug delivery. Based on type, the global long-term asthma drugs market is segmented into tablets and sprays. The tablet segment is expected to account for a larger share of the market than the spray segment during the forecast period. This can be attributed to factors such as ease of use and lower cost as compared to sprays. Based on application, the global long-term asthma drugs market is divided into hospital pharmacy, online pharmacy, and retail pharmacy segments.
Product Definition:
Long-term asthma drugs are used to prevent and control symptoms of asthma. They are taken every day to help keep the airways open.
Tablet:
Tablet is a form of drug delivery technology that has evolved from the pen and paper. The first tablet was launched in Germany in 1920 by Dr. Maximilian Boehringer and today, more than 100 years later, there are over 4,000 different types of tablets available globally with various trade names such as Amrix, Datumox etc.
Spray:
Spray is a nebulizer-based drug delivery device that delivers medication to the lungs. It is an asthma inhaler and works by causing airway irritation, which causes inflammation and blocks tiny airways in the lungs. The spray consists of dry powder formulation of drugs that are compressed into a small container with a propellant.
Application Insights:
The hospital pharmacy segment accounted for the largest revenue share in 2016. This is owing to factors such as presence of a large patient base with asthma and rising prevalence of the disease. According to WHO, it was estimated that globally around 1 in 3 children suffers from asthma and approximately 2.4 million died due to this condition in 2015, which represents a mortality rate of 4 per 100,000 population every year. Thus, increasing number of patients suffering from chronic respiratory diseases including asthma is expected to boost demand for long-term asthmabuy online or from hospital pharmacies over the forecast period.
Online pharmacy has been witnessing significant growth over recent years owing to easy access and convenience associated with it.
Regional Analysis:
North America dominated the global long-term asthma drugs market in 2017. This is due to the presence of a large number of key players, high healthcare expenditure and availability of advanced treatment options for patients. Moreover, increasing prevalence of respiratory diseases coupled with an aging population is also expected to drive growth over the forecast period. Asia Pacific region is anticipated to witness lucrative growth during the forecast period owing to rising disposable income and improving economic conditions in emerging countries such as India & China.
The European region accounted for a significant share in terms of revenue generation owing to growing awareness regarding various treatment options available for LTA patients coupled with favorable reimbursement policies implemented by governments across Europe (excluding UK).
Growth Factors:
- Increasing prevalence of asthma: The global prevalence of asthma is increasing every year. This will drive the demand for long-term asthma drugs in the market.
- Growing awareness about long-term asthma drugs: There is a growing awareness among people about the benefits of using long-term asthma drugs. This will help to drive the growth of this market in the coming years.
- Technological advancements in long-term asthma drugs: The pharmaceutical companies are constantly working on developing new and better technologies for manufacturing long-term asthma drugs. This will help to boost the growth of this market in future years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Long-Term Asthma Drugs Market Research Report
By Type
Tablet, Spray
By Application
Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
By Companies
Pfizer, GlaxoSmithKline, Novartis, Merck, Boehringer Ingelheim, AstraZeneca, Roche, Teva Pharmaceutical, Vectura Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
166
Number of Tables & Figures
117
Customization Available
Yes, the report can be customized as per your need.
Global Long-Term Asthma Drugs Market Report Segments:
The global Long-Term Asthma Drugs market is segmented on the basis of:
Types
Tablet, Spray
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- GlaxoSmithKline
- Novartis
- Merck
- Boehringer Ingelheim
- AstraZeneca
- Roche
- Teva Pharmaceutical
- Vectura Group
Highlights of The Long-Term Asthma Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablet
- Spray
- By Application:
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Long-Term Asthma Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Long-term asthma drugs are medications that are taken over a period of time to control asthma symptoms. These medications can be taken as pills, inhalers, or injections. They work by reducing the amount of air that is breathed in and help to prevent episodes of asthma.
Some of the major companies in the long-term asthma drugs market are Pfizer, GlaxoSmithKline, Novartis, Merck, Boehringer Ingelheim, AstraZeneca, Roche, Teva Pharmaceutical, Vectura Group.
The long-term asthma drugs market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Long-Term Asthma Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Long-Term Asthma Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Long-Term Asthma Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Long-Term Asthma Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Long-Term Asthma Drugs Market Size & Forecast, 2018-2028
4.5.1 Long-Term Asthma Drugs Market Size and Y-o-Y Growth
4.5.2 Long-Term Asthma Drugs Market Absolute $ Opportunity
Chapter 5 Global Long-Term Asthma Drugs Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Long-Term Asthma Drugs Market Size Forecast by Type
5.2.1 Tablet
5.2.2 Spray
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Long-Term Asthma Drugs Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Long-Term Asthma Drugs Market Size Forecast by Applications
6.2.1 Hospital Pharmacy
6.2.2 Online Pharmacy
6.2.3 Retail Pharmacy
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Long-Term Asthma Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Long-Term Asthma Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Long-Term Asthma Drugs Analysis and Forecast
9.1 Introduction
9.2 North America Long-Term Asthma Drugs Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Long-Term Asthma Drugs Market Size Forecast by Type
9.6.1 Tablet
9.6.2 Spray
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Long-Term Asthma Drugs Market Size Forecast by Applications
9.10.1 Hospital Pharmacy
9.10.2 Online Pharmacy
9.10.3 Retail Pharmacy
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Long-Term Asthma Drugs Analysis and Forecast
10.1 Introduction
10.2 Europe Long-Term Asthma Drugs Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Long-Term Asthma Drugs Market Size Forecast by Type
10.6.1 Tablet
10.6.2 Spray
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Long-Term Asthma Drugs Market Size Forecast by Applications
10.10.1 Hospital Pharmacy
10.10.2 Online Pharmacy
10.10.3 Retail Pharmacy
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Long-Term Asthma Drugs Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Long-Term Asthma Drugs Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Long-Term Asthma Drugs Market Size Forecast by Type
11.6.1 Tablet
11.6.2 Spray
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Long-Term Asthma Drugs Market Size Forecast by Applications
11.10.1 Hospital Pharmacy
11.10.2 Online Pharmacy
11.10.3 Retail Pharmacy
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Long-Term Asthma Drugs Analysis and Forecast
12.1 Introduction
12.2 Latin America Long-Term Asthma Drugs Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Long-Term Asthma Drugs Market Size Forecast by Type
12.6.1 Tablet
12.6.2 Spray
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Long-Term Asthma Drugs Market Size Forecast by Applications
12.10.1 Hospital Pharmacy
12.10.2 Online Pharmacy
12.10.3 Retail Pharmacy
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Long-Term Asthma Drugs Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Long-Term Asthma Drugs Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Long-Term Asthma Drugs Market Size Forecast by Type
13.6.1 Tablet
13.6.2 Spray
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Long-Term Asthma Drugs Market Size Forecast by Applications
13.10.1 Hospital Pharmacy
13.10.2 Online Pharmacy
13.10.3 Retail Pharmacy
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Long-Term Asthma Drugs Market: Competitive Dashboard
14.2 Global Long-Term Asthma Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 GlaxoSmithKline
14.3.3 Novartis
14.3.4 Merck
14.3.5 Boehringer Ingelheim
14.3.6 AstraZeneca
14.3.7 Roche
14.3.8 Teva Pharmaceutical
14.3.9 Vectura Group
